Trial Summary:

ESCAPE-CS aims to determine if implementation of a comprehensive ‘best-practice’ model of CS care, comprising a streamlined referral system, a multidisciplinary shock team, and protocols to inform clinical decision-making, improves all-cause mortality, 30-days post index admission, when compared to rates documented in usual care.

Supported By:

NHMRC Medical Research Future Fund Public Grant

Eligibility:

Adult inpatients diagnosed with cardiogenic shock, from any cause, at a participating study site.

Registration ID:

TBC

Participation:

Australia

Status:

Start Up

Activation Date:

N/A

Chairs:

Dr Pankaj Jain (Chief Investigator)

Contact:

Escapce-cs.study@sydney.edu.au